(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MDX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MDX

ST13

US500000097437069

Class

5, 44

Filing

97437069

Registration

7256207

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

12/26/2023

Trademark type

Combined

Nice classes

5, 44

Filing date

05/31/2022

Registration date

12/26/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/26/2023

Last transaction

12/26/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2022-03-00

First use in commerce

07/12/2023

Drawing code

5

Owner type

99

Owner location

Liege, BE

Examiner

FRENCH, CURTIS

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the letters M and D, in lower case and the letter X in stylized form.

Holders and representatives

Holders

MDXHealth S.A.

Representatives

Neal Wolgin TILLMAN, WRIGHT & WOLGIN

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectioncancer

Class 44

Medical testing services relating to the diagnosis and treatment of disease

Publications

History of USPTO decisions and trademark events.

20 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/26/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

12/26/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/22/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/21/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/15/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/14/2023

EX1G

SOU EXTENSION 1 GRANTED

11/14/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/14/2023

IUAF

USE AMENDMENT FILED

11/07/2023

EXT1

SOU EXTENSION 1 FILED

11/07/2023

EEXT

SOU TEAS EXTENSION RECEIVED

11/07/2023

EISU

TEAS STATEMENT OF USE RECEIVED

11/07/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/09/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/14/2023

PUBO

PUBLISHED FOR OPPOSITION

03/14/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/22/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/07/2023

DOCK

ASSIGNED TO EXAMINER

02/01/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/08/2022

NWAP

NEW APPLICATION ENTERED

06/03/2022

Continuous trademark protection

Get notified about every new filing that threatens MDX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.